Navigation Links
EntreMed's Aurora Kinase Inhibitor Induces Tumor Regression in,Preclinical Models

ROCKVILLE, Md., June 01, 2007 /PRNewswire-FirstCall/ -- EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced the presentation of preclinical results for its Aurora kinase - angiogenesis inhibitor, ENMD-981693. The data were presented during oral and poster presentations by EntreMed scientists at the 2nd Protein Kinases in Drug Discovery Conference being held May 31 - June 1, 2007 in Boston, Massachusetts.

ENMD-981693 is an oral, dual-acting kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. In preclinical studies, ENMD-981693 has been shown to inhibit a unique profile of angiogenic tyrosine kinase targets in addition to the Aurora kinases. Aurora kinases are key regulators of mitosis (cell division), and are often over-expressed in human cancers. ENMD-981693 is selective for the Aurora A isoform in comparison to Aurora B.

Results from in vitro studies demonstrate ENMD-981693's potent activity against oncogenic receptor tyrosine kinases, including FLT3, c-Kit and CSF1R, which are involved in the pathology of hematological cancers. Additionally, ENMD-981693 demonstrated potent inhibition of a spectrum of targets linked to angiogenesis, including KDR (VEGFR2) and FGFR1. The compound was also shown to induce apoptosis and cell cycle arrest in a broad range of cell lines.

ENMD-981693 exhibited antiangiogenic activity in in vivo animal models by preventing the formation of new blood vessels and inducing regression of formed vessels at well-tolerated doses. Orally-administered ENMD-981693 induced tumor regression with minimal toxicity in a preclinical xenograft model of human leukemia. This activity is consistent with tumor regression induced by ENMD-981693 in preclinical models of human tumors derived from colon, leukemia, and breast cancer cell lines.

Mark
'"/>




Page: 1 2 3

Related medicine technology :

1. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
2. Phase 2 Results for EntreMeds Panzem NCD Brain Cancer Study Presented at ASCO
3. Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
4. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Suppresses Critical Double-Stranded DNA Repair Protein, Rad51
5. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
6. AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and Drug-Resistant Lung Cancer
7. Pharmacyclics Announces Presentations on Its Novel and Selective HDAC and Brutons Tyrosine Kinase Inhibitor Compounds
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
10. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
11. Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection
Post Your Comments:
(Date:7/10/2014)... July 10, 2014  Breg, Inc., a premier ... launched the FreeRunner™ knee brace with new innovations ... patella mal-tracking return to active lifestyles.  FreeRunner,s patent-pending ... braces, providing support when patients need it most, ... don,t. Patellofemoral issues are the most ...
(Date:7/10/2014)... 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... completed the sale to Galderma of all rights to ... by Valeant for $1.4 billion in cash, pursuant to ... completed its acquisition of Galderma. "We ... to a company that is firmly committed to the ...
(Date:7/10/2014)... Mass. , July 10, 2014 Decision ... report awareness of the U.S. Food and Drug Administration,s ... new phosphate binder Velphoro, which was approved by the ... in chronic kidney disease (CKD) patients on dialysis. ... TreatmentTrends: Nephrology (US) Q2 2014 : ...
Breaking Medicine Technology:Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
... The Medical Oncology Association of Southern California ... an agreement to work together to expand use ... costs of cancer care in Southern California. ... and distribution services to help health care professionals, ...
... The American Society of Bariatric Physicians (ASBP) is sad ... go out to his family, friends and fans.  The recent ... a contributing factor to his death are concerning and bring ... prescribed. While the specific details of Bubba ...
Cached Medicine Technology:Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care 2Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care 3Physicians Who Treat Obesity Respond to the News of Bubba Smith's Overdose 2
(Date:7/11/2014)... July 11, 2014 Wearing the school motto ... families, facility and staff came together this past Saturday morning ... Everest community in the Homer Township Independence Day Parade. ... Old Glory. , Everest community recognized the theme ... in red, white and blue. The blue Everest balloons ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Growing old was thought ... then. However, in recent studies, it was shown that many of ... credence behind them. As it turns out, the elderly can still ... , Of course, with all the time in the world, older ... them to indulge their passions in the twilight of their lives. ...
(Date:7/11/2014)... Newport Beach, CA (PRWEB) July 11, 2014 ... product pure Artichoke Leaf Extract dietary supplements to aid ... flow, an action necessary to facilitate metabolism of fat. ... facilities, Superior Labs Artichoke Leaf Extract is available in ... of pure artichoke extract. , Health Benefits of ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Plasma resource ... blood products industry. Although the closure of 16 plasma ... disruption to domestic blood products market, the total plasma ... year on year and total lot release volume declined ... to stock consumption, insufficient utilization of new plasma stations ...
(Date:7/11/2014)... New Mexico (PRWEB) July 11, 2014 ... stress disorder are just some of the increasing numbers ... them to lead more independent and productive lives. ... the workplace? Or is an assistance dog an impediment ... Assistance Dog Week , August 3 - 9, 2014, ...
Breaking Medicine News(10 mins):Health News:Everest Academy Participates in the Homer Township Independence Day Parade 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 3Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 2Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 2Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 4Health News:Will Your Next Employee or Co-Worker Be a Dog? 2Health News:Will Your Next Employee or Co-Worker Be a Dog? 3Health News:Will Your Next Employee or Co-Worker Be a Dog? 4
... Categories of Customer ... Satisfaction, According to MD Buyline, NASHUA, N.H., ... of Computer-Aided Detection (CAD),solutions for the early detection of ... satisfaction ratings in the,Mammography CAD market, according to the ...
... 29, 2008, Presenting at the BMO Capital Markets Focus ... ... LCA-Vision Inc. (Nasdaq:,LCAV), a leading provider of laser vision ... events., Second Quarter 2008 Financial Results, LCA-Vision will ...
... researchers report , , THURSDAY, July 10 (HealthDay News) ... damaged muscle in mice with a form of muscular ... skeletal muscle. , There,s no guarantee that the treatment ... author Amy Wagers, an assistant professor in Harvard University,s ...
... Many vitamin pills and tablets such as pain killers ... This will often incorporate some form of desiccant to ... in the tube stops the contents from rattling around. ... to lose and require two hands to manipulate. Customers ...
... Utah, July 10 Merit Medical,Systems, Inc. (Nasdaq: ... of,proprietary disposable devices used primarily in cardiology and ... quarter ended June,30, 2008 were approximately $57.4 million, ... 2007, which the Company believes will produce earnings ...
... Stand Behind Our ... Troops, ... creating awareness for the most underserved and,at-risk groups in our country, today ... is to assist those soldiers,who have been wounded in conflict in the ...
Cached Medicine News:Health News:iCAD Achieves Record-High Ratings in Mammography CAD User Satisfaction 2Health News:iCAD Achieves Record-High Ratings in Mammography CAD User Satisfaction 3Health News:LCA-Vision Announces Upcoming Investment Community Events 2Health News:Stem Cells Hold Promise for Muscular Dystrophy 2Health News:Integrated tube cap design simplifies access to medication 2Health News:Merit Medical Pre-Announces Record Sales and Earnings for the Second Quarter Ended June 30, 2008 2Health News:Merit Medical Pre-Announces Record Sales and Earnings for the Second Quarter Ended June 30, 2008 3Health News:Purple Dog Tag Launches; Provides Hope and Healing to Thousands of US Servicemen & Veterans 2
... Operation: , Double Burst : 2 60-ms bursts of ... s (1 pulse/s) , Tetanus: 50 Hz (50 ... Single (4 pulses/2 s) , Output Current: Adjustable from ... pulses (200-us duration) , Indicators: Battery LED (green) indicates ...
... of Operation: , Standby: A standby switch maintains ... , Twitch: 1 s (1 pulse/s) , ... (4 pulses/2 s) , Output Current: Adjustable from ... Monophasic pulses (200-us duration) , Indicators: Battery LED ...
Anesthesia Associates Model 100 Compact Peripheral Nerve Stimulator, incorporates the latest state-of-the-art electronics with solid state cicuitry to ensure trouble-free operation and extended batte...
... the newest peripheral nerve stimulator from B. Braun ... stimulators providing advanced digital technology. , ,Your ... HNS11 allows the localization of practically all mixed ... ,An additional optional component for the HNS11 ...
Medicine Products: